Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Venous Thromboembolism in Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01602445
What this trial is testing

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep-Vein ThrombosisPulmonary Embolism+1 more
Ottawa Hospital Research Institute 700
Large-scale testing (Phase 3)Ended earlyNCT05171049
What this trial is testing

A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism
Anthos Therapeutics, Inc. 1,150
Not applicableActive Not RecruitingNCT07008508
What this trial is testing

Incidence of Venous Thromboembolism and Cardiovascular Events in Breast Cancer Patients Undergoing Cyclin-dependent Kinase 4/6 Inhibitors: The Breast Cancer Associated Vascular Events During Cyclin-dependent Kinase 4/6 Inhibitors Therapy (BRAVE-Cyclin) Study

Who this might be right for
Breast Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 300
Not applicableStudy completedNCT04979780
What this trial is testing

Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort

Who this might be right for
Treatment of Venous Thromboembolism in Cancer PatientsProphylaxis of Recurrent Venous Thromboembolism in Cancer Patients
Bayer 3,708
Not applicableLooking for participantsNCT06284343
What this trial is testing

The Gynecological Cancer Associated Thrombosis (GynCAT) Study

Who this might be right for
Cancer-associated ThrombosisVenous ThromboembolismGynecologic Cancer+4 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,800
Post-approval studies (Phase 4)Study completedNCT00966277
What this trial is testing

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

Who this might be right for
Pancreatic CancerVenous Thromboembolism
M.D. Anderson Cancer Center 87
Not applicableStudy completedNCT05461807
What this trial is testing

An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism)

Who this might be right for
Treatment of Venous Thromboembolism in Cancer PatientsVenous ThromboembolismCancer
Bayer 2,437
Large-scale testing (Phase 3)Ended earlyNCT05171075
What this trial is testing

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism
Anthos Therapeutics, Inc. 417
Not applicableStudy completedNCT03965741
What this trial is testing

Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners

Who this might be right for
Venous Thromboembolism (VTE)
Bayer 97,765
Not applicableStudy completedNCT02502396
What this trial is testing

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

Who this might be right for
CancerDeep-vein Thrombosis of the Lower and Upper ExtremitiesPulmonary Embolism+1 more
M.D. Anderson Cancer Center 265
Large-scale testing (Phase 3)Study completedNCT03045406
What this trial is testing

Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer

Who this might be right for
Venous Thromboembolism
Fadoi Foundation, Italy 1,170
Large-scale testing (Phase 3)Study completedNCT02555878
What this trial is testing

Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 841
Large-scale testing (Phase 3)Study completedNCT03080883
What this trial is testing

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Who this might be right for
Cerebral Vein ThrombosisDeep Vein ThrombosisHematopoietic and Lymphoid Cell Neoplasm+4 more
Academic and Community Cancer Research United 370
Not applicableUnknownNCT02017743
What this trial is testing

Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Trio Grup Clinical Research 200
Not applicableStudy completedNCT03114618
What this trial is testing

A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient

Who this might be right for
Cancer-associated ThrombosisGenetic Predisposition
Andres muñoz 416
Large-scale testing (Phase 3)Study completedNCT02746185
What this trial is testing

Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban

Who this might be right for
NeoplasmVenous Thromboembolism
Assistance Publique - Hôpitaux de Paris 159
Not applicableStudy completedNCT03134820
What this trial is testing

Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease

Who this might be right for
Venous ThromboembolismPulmonary ThromboembolismsCancer
Delos Clinical 352
Testing effectiveness (Phase 2)Ended earlyNCT03195010
What this trial is testing

Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+11 more
Fred Hutchinson Cancer Center 4
Large-scale testing (Phase 3)Study completedNCT02066454
What this trial is testing

Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs

Who this might be right for
MyelomaVenous Thromboembolism
University Hospital, Grenoble 108
Not applicableStudy completedNCT02922543
What this trial is testing

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

Who this might be right for
Multiple Myeloma
Celgene 361
Next Page